Page last updated: 2024-08-25

2-aminopyrazine and Myositis Ossificans

2-aminopyrazine has been researched along with Myositis Ossificans in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Arista, L; Broennimann, V; Guth, S; Head, V; Kramer, I; Stiefl, N; Teixeira-Fouchard, S; Ullrich, T; Weiler, S1

Other Studies

1 other study(ies) available for 2-aminopyrazine and Myositis Ossificans

ArticleYear
Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva.
    Bioorganic & medicinal chemistry letters, 2022, 05-15, Volume: 64

    Topics: Activin Receptors, Type I; Humans; Myositis Ossificans; Ossification, Heterotopic; Pyrazines; Signal Transduction

2022